General Dermatology
Eczema
Chronic Hand Eczema
Alopecia
Aesthetics
Vitiligo
COVID-19
Actinic Keratosis
Precision Medicine and Biologics
Rare Disease
Wound Care
Rosacea
Psoriasis
Psoriatic Arthritis
Atopic Dermatitis
Melasma
NP and PA
Skin Cancer
Hidradenitis Suppurativa
Drug Watch
Pigmentary Disorders
Acne
Pediatric Dermatology
Practice Management
Prurigo Nodularis

News

Article

September 21, 2024

Derm In The News: September 15-21

Author(s):

Keep up with the latest headlines in dermatology from the past week, including data on AI versus dermatology residents, permanent makeup and the risk of allergic contact dermatitis, and more.

WKRN News 2: ChatGPT vs Dermatology Residents on Exam Questions

A recent study published in SKIN: The Journal of Cutaneous Medicine assessed the performance of ChatGPT 4.0 on dermatology boards-style practice questions. Researchers evaluated ChatGPT's accuracy on 300 questions from DermQBank, including text-only and image-based questions. The AI correctly answered 77.3% of the questions, performing better with text-only questions than those with images. However, it performed worse than over half of dermatology trainees and incorrectly answered 22.7% of the time.

Medical Dialogues: Permanent Makeup Pigments Increase Risk of Allergic Contact Dermatitis, finds research

A recent study indicates that permanent makeup pigments can heighten the risk of allergic contact dermatitis, particularly from inorganic compounds like iron oxides and titanium dioxide. Symptoms such as redness, itching, and swelling may develop months or even years post-procedure. The findings underscore the need for better regulation and thorough pre-procedure testing to minimize risks.

Patient-Forward Rundown

Top headlines from this week to share with your patients:

WWLTV.com: Longtime New Orleans dermatologist dies at 90

Nia Terezakis, MD, a respected New Orleans dermatologist, passed away at age 90. A graduate of Tulane School of Medicine and former LSU School of Medicine resident, she had a long career in the region. Terezakis was known for her research on topical retinoids for hair growth and authored a book titled The 'Art' of the Meal.

Yahoo Finance: Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%

Organon has announced plans to acquire Dermavant Sciences, enhancing its US dermatology portfolio. Dermavant's Vtama cream, a non-steroidal treatment for plaque psoriasis, was FDA-approved in 2022 and is under review for atopic dermatitis. The acquisition will combine Dermavant's US expertise with Organon's global reach, aiming to provide innovative dermatology treatments for conditions affecting millions, particularly women.

Read more from Dermatology Times.

KTLA: Melbourne Skin & Dermatology Launches State-of-the-Art Skin Cancer Detection and Treatment Program

Melbourne Skin & Dermatology has launched a new program dedicated to advanced skin cancer detection and treatment. This initiative enhances the clinic’s ability to identify and manage skin cancer using cutting-edge technology and techniques, such as high-resolution imaging and dermoscopy for accurate evaluations. The program emphasizes patient-centered care, with personalized consultations to address individual risk factors and develop tailored prevention strategies.

Have you seen any dermatology headlines this week that we may have missed? Share with us by emailing our team at DTEditor@mmhgroup.com.